Cargando…

Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1

HAD-B1 is a Korean herbal formula designed to treat solid tumors, and through cell experiments, it has proven to have an anticancer effect. The current study aims to test the safety of HAD-B1. This experiment is under the regulation of ICH. In order to find if HAD-B1 has any effect on the CNS, 0, 50...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Soo-Dam, Yang, Jae-Ho, Kwag, Eun-Bin, Park, Ji-Hye, Park, So-Jung, Yoo, Hwa-Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594988/ https://www.ncbi.nlm.nih.gov/pubmed/34795778 http://dx.doi.org/10.1155/2021/2162986

Ejemplares similares

Acute and Subchronic Toxicological Evaluation of the Herbal Product HAD-B1 in Rats
por: Park, So-Jung, et al.
Publicado: (2021)

Acute and sub-chronic toxicological evaluation of the herbal product HAD-B1 in Beagle dogs
por: Song, Si-Yeon, et al.
Publicado: (2021)

Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Evaluate the Efficacy and Safety of HAD-B1 for Dose-Finding in EGFR Mutation Positive and Locally Advanced or Metastatic NSCLC Subjects Who Need Afatinib Therapy
por: Ko, Eun-Ju, et al.
Publicado: (2021)

The Current Status of Integrative Oncology in Korea
por: Kwag, Eun-Bin, et al.
Publicado: (2021)

Efficacy and Safety of Ginger on the Side Effects of Chemotherapy in Breast Cancer Patients: Systematic Review and Meta-Analysis
por: Kim, Soo-Dam, et al.
Publicado: (2022)

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
por: Pollack, Pia S., et al.
Publicado: (2017)

Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer
por: Song, Si Yeon, et al.
Publicado: (2022)

Qualitative Analysis of Proteins in Two Snake Venoms, Gloydius Blomhoffii and Agkistrodon Acutus
por: Ha, Su-Jeong, et al.
Publicado: (2022)

Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study
por: Ha, Su-Jung, et al.
Publicado: (2023)

Selective Immune Modulating Activities of Viscum album and Its Components; A Possibility of Therapeutics on Skin Rash Induced by EGFR Inhibitors
por: Choi, Hye Jin, et al.
Publicado: (2022)

Strategies for the Nonclinical Safety Assessment of Vaccines
por: Wolf, Jayanthi J., et al.
Publicado: (2012)

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
por: Song, Si-Yeon, et al.
Publicado: (2020)

Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice
por: Kang, Hwa Jeong, et al.
Publicado: (2019)

The Survival Benefit of Combination Therapy With Mild Temperature Hyperthermia and an Herbal Prescription of Gun-Chil-Jung in 54 Cancer Patients Treated With Chemotherapy or Radiation Therapy: A Retrospective Study
por: Jun, Hyeong Joon, et al.
Publicado: (2020)

Book Review: Toxicologic Pathology, Nonclinical Safety Assessment
por: Yoshizawa, Katsuhiko
Publicado: (2014)

Considerations for the Nonclinical Safety Evaluation of Antibody–Drug Conjugates
por: Fisher, J. Edward
Publicado: (2021)

Regulatory Consideration for the Nonclinical Safety Assessment of Gene Therapies
por: Moffit, Jeffrey S., et al.
Publicado: (2022)

Preparing pathological data to develop an artificial intelligence model in the nonclinical study
por: Hwang, Ji-Hee, et al.
Publicado: (2023)

Multi-center, randomized, double-blind, placebo-controlled, exploratory study to evaluate the efficacy and safety of HAD-B1 for dose-finding in EGFR positive and locally advanced or metastatic NSCLC subjects who need Afatinib therapy: Study protocol clinical trial (SPIRIT Compliant)
por: Park, So-Jung, et al.
Publicado: (2020)

Nonclinical safety evaluation of food colorant lac dye via systematic toxicity profiling with assessment of in vivo antigenic potential
por: Park, Jin-Sung, et al.
Publicado: (2022)

Practical approaches for evaluating adrenal toxicity in nonclinical safety assessment
por: Inomata, Akira, et al.
Publicado: (2015)

Galectin-3-independent Down-regulation of GABABR1 due to Treatment with Korean Herbal Extract HAD-B Reduces Proliferation of Human Colon Cancer Cells
por: Kim, Kyung-Hee, et al.
Publicado: (2012)

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711
por: Lindström, Erik, et al.
Publicado: (2018)

Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
por: Roch, Catherine, et al.
Publicado: (2021)

Clinical Utility of Beck Anxiety Inventory in Clinical and Nonclinical Korean Samples
por: Oh, Hyeonju, et al.
Publicado: (2018)

Safety Assessment of Mainstream Smoke of Herbal Cigarette
por: Bak, Jong Ho, et al.
Publicado: (2015)

Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology
por: Lee, Ho-Sung, et al.
Publicado: (2022)

S73. RELATIONSHIP OF COGNITIVE ABILITY AND PERSONALITY TRAITS WITH HOSTILE ATTRIBUTION BIAS IN NONCLINICAL SUBJECTS: THEORY OF MIND AS A MEDIATOR
por: Jun Koo, Se, et al.
Publicado: (2020)

Development of Hazardous Materials Management Standard for Decoction Type of Personalized Herbal Medicine
por: Jeong, Hye-In, et al.
Publicado: (2020)

The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies
por: Janas, Maja M., et al.
Publicado: (2018)

Efficacy and Safety of Korean Herbal Medicine for Patients with Post-Accident Syndrome, Persistent after Acute Phase: A Pragmatic Randomized Controlled Trial
por: Hwang, Bo-Kyung, et al.
Publicado: (2023)

Laparoscopic and Robotic Surgeries for Patients With Colorectal Cancer Who Have Had a Previous Abdominal Surgery
por: Park, Soeun, et al.
Publicado: (2017)

Had1 Is Required for Cell Wall Integrity and Fungal Virulence in Cryptococcus neoformans
por: Jung, Won-Hee, et al.
Publicado: (2017)

Efficacy and Safety of Yukgunja-Tang for Patients with Cancer-related Anorexia: A Randomized, Controlled Trial, Pilot Study
por: Ko, Myung-Hyun, et al.
Publicado: (2021)

Nonclinical statistics for pharmaceutical and biotechnology industries
por: Zhang, Lanju
Publicado: (2016)

Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma‐derived human FXIII concentrate in animals
por: Beyerle, Andrea, et al.
Publicado: (2016)

Nonclinical safety, tolerance and pharmacodynamics evaluation for meplazumab treating chloroquine-resistant Plasmodium falciparum
por: Zhang, Kun, et al.
Publicado: (2020)

Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
por: Singh, Shweta, et al.
Publicado: (2022)

Herbal medicine (Jogyeongseongjang decoction) for precocious puberty girls: a retrospective study
por: Shim, Soo Bo, et al.
Publicado: (2020)

Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation
por: Lee, Ho-Sung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i1egvhv922ci7g4ebfvqfap7l7